GILLIES HUNTER (Chief Medical Officer) sold 51.7% of their position (6K shares) of JADE BIOSCIENCES, INC. on the open market
Open‑market sale worth $147.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/14/2024ACC: 0001415889-24-016993
Officer· Chief Medical Officer
Since Jun 2021
-6K
Net shares
Net seller
$147.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6K acquired · 12K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6K
Price / share
$2.14
Trade value
$12.84K
% of position
107.1%
6/13/2024
5.60K→11.60K
Common Stock
Direct
Shares
−6K
Price / share
$24.50
Trade value
$147K
% of position
51.7%
6/13/2024
11.60K→5.60K
Total
Net shares
+0.00
Net value
-$134.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2024 | M · Option Exercise | +6K | $2.14 | $12.84K | 107.1% | 5.60K | 11.60K |
| Common Stock Direct | 6/13/2024 | S · Sale | −6K | $24.50 | $147K | 51.7% | 11.60K | 5.60K |
| Total | +0.00 | -$134.16K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
6K shares
Shares
−6K
Strike price
2.14
Held after
83.51K
Exercisable
—
6/13/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock6K shares | 6/13/2024 | M · Option Exercise | −6K | 2.14 | — | 83.51K |